Hepatitis C virus entry depends on clathrin-mediated endocytosis

Area of Science:

• Virology
• Cell Biology
• Infectious Diseases

Background:

• Hepatitis C virus (HCV) entry mechanisms are not fully understood due to cell culture challenges.
• Investigating HCV entry is crucial for developing effective antiviral strategies.

Purpose of the Study:

• To elucidate the postbinding cellular mechanisms of HCV entry.
• To determine the role of clathrin-mediated endocytosis and endosomal acidification in HCV infection.

Main Methods:

• Utilized retroviral particles pseudotyped with HCV glycoproteins (HCVpp) and cell culture-propagated HCV (HCVcc).
• Assessed HCV entry via quantitative real-time PCR and infection via immunoblot and immunofluorescence.
• Inhibited clathrin-mediated endocytosis using siRNA and chlorpromazine.
• Examined the effect of endosomal acidification inhibitors (bafilomycin A1, chloroquine) on HCVcc infection.

Main Results:

• HCVpp entry and HCVcc infection were significantly inhibited by blocking clathrin-mediated endocytosis.
• HCVcc infection was also inhibited by bafilomycin A1 and chloroquine, indicating a requirement for endosomal acidification.
• These findings confirm clathrin-mediated endocytosis as the entry pathway for HCV.

Conclusions:

• HCV utilizes clathrin-mediated endocytosis for cellular entry.
• A subsequent fusion event within an acidic endosomal compartment is essential for HCV infection.
• This study provides critical insights into the molecular mechanisms of HCV cell entry.